[1]
Sobirdjanovna, K.N., Mirkomil, T., Siyovush, S., Zoyirjon, T. and Dilorom, O. 2024. Pros and Cons of Using a Combination of Glow-Lowing Drugs, In Particular Dpp-4 Inhibitors and Metformin in Patients with Type 2 Diabetes and Overweight. Journal of Science in Medicine and Life. 2, 4 (Apr. 2024), 50–53.